Biosimilars Market - Company Profile (Novartis (Sandoz), Synthon Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., LG Life Sciences, Celltrion, Biocon, Hospira, Merck Serono (Merck Group), Biogen idec, Inc., and Genentech (Roche Group).)and Competitive intelligence report 2017

TOC

Chapter: 1 COMPANY PROFILES

1.1 Novartis (Sandoz)

1.1.1 Company overview

1.1.2 Company snapshot

1.1.3 Operating business segment overview

1.1.4 Business performance

1.1.5 Key strategies

1.1.5.1 Primary Strategies: Clinical Trials

1.1.5.2 secondary Strategies: approval

1.1.6 SWOT analysis

1.2 Synthon Pharmaceuticals, Inc.

1.2.1 Company overview

1.2.2 Company snapshot

1.2.3 Operating business segment overview

1.2.4 Key strategies

1.2.4.1 Primary Strategies: agreement

1.2.4.2 secondary Strategies: clinical trials

1.2.5 SWOT analysis

1.3 Teva Pharmaceutical Industries Ltd.

1.3.1 Company Overview

1.3.2 Company Snapshot

1.3.3 Operating business segment overview

1.3.4 Business performance

1.3.5 Key strategies

1.3.5.1 Primary Strategies: approval

1.3.5.2 secondary Strategies: clinical trials

1.3.6 SWOT analysis

1.4 LG Life Sciences

1.4.1 Company overview

1.4.2 Company snapshot

1.4.3 Operating business segment overview

1.4.4 Business performance

1.4.5 Key strategies

1.4.5.1 Primary Strategies: Collaboration

1.4.6 SWOT analysis

1.5 Celltrion

1.5.1 Company overview

1.5.2 Company snapshot

1.5.3 Operating business segment overview

1.5.4 Business Performance

1.5.5 Key strategies

1.5.5.1 Primary Strategies: approval

1.5.6 SWOT analysis

1.6 Biocon

1.6.1 Company overview

1.6.2 Company snapshot

1.6.3 Operating business segment overview

1.6.4 Business Performance

1.6.5 Key strategies

1.6.5.1 Primary Strategy: product launch

1.6.5.2 secondary Strategy: clinical trial

1.6.6 SWOT analysis

1.7 Hospira

1.7.1 Company overview

1.7.2 Company snapshot

1.7.3 Operating business segment overview

1.7.4 Business performance

1.7.5 Key strategies

1.7.5.1 Primary Strategies: approval

1.7.5.2 secondary Strategies: clinical trials

1.7.6 SWOT analysis

1.8 Merck Serono (Merck Group)

1.8.1 Company overview

1.8.2 Company snapshot

1.8.3 Operating business segment overview

1.8.4 Business performance

1.8.5 Key strategies

1.8.5.1 Primary Strategies: partnership and product launch

1.8.6 SWOT analysis

1.9 Biogen idec Inc.

1.9.1 Company overview

1.9.2 Company snapshot

1.9.3 Operating business segment overview

1.9.4 Business performance

1.9.5 Key strategies

1.9.5.1 Primary Strategies: agreement and joint venture

1.9.6 SWOT analysis

1.10 Genentech (Roche Group)

1.10.1 Company overview

1.10.2 Company snapshot

1.10.3 Operating business segment overview

1.10.4 Key strategies

1.10.4.1 Primary Strategies: Investment and license

1.10.5 SWOT analysis

LIST OF TABLES AND FIGURES

-